Adverse Events of the Port Delivery System and Addressing Challenges With Adoption

Author(s):

Aleksandra Rachitskaya, MD,Jordan Graff, MD, FACS

Panelists discuss how careful patient selection and management of potential complications - including surgical risks, device-related adverse events, and cost-benefit considerations requiring operating room resources - are crucial factors in successfully implementing the port delivery system in clinical practice.

EP: 1.Overview of Novel Treatments for Retinal Vascular Diseases

EP: 2.Overview and Benefits of Port Delivery System with Ranibizumab

EP: 3.Patient Selection for Port Delivery System

EP: 4.Considerations for Surgical Implant of the Port Delivery System and Refill Process

EP: 5.Key Steps in the Surgical Implantation of the Port Delivery System

EP: 6.Patient Experiences, Key Clinical Trial Outcomes of the Port Delivery System

Now Viewing

EP: 7.Adverse Events of the Port Delivery System and Addressing Challenges With Adoption

EP: 8.Novel Intravitreal Injections: Faricimab and Aflibercept 8mg for the Treatment of Retinal Diseases

Video content above is prompted by the following:

What are the major adverse effects associated with the PDS, and which patients are not suitable candidates for this delivery system?
What are some potential challenges to the adoption of the PDS, and how can retina specialists and surgeons address these to facilitate its integration into clinical practice?
Need to go to the operating room- balancing cost versus benefits

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!